首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1781438

全球伴侶動物藥品市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及 2025 年至 2033 年預測

Global Companion Animal Pharmaceuticals Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年08月01日 | 出版商:

Value Market Research | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球伴侶動物藥品市場規模預計將從 2024 年的 188.1 億美元成長到 2033 年的 303.5 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 預計將達到 5.46%。

隨著全球寵物擁有量持續成長，寵物的健康和福祉也日益受到重視，伴侶動物藥品市場可望迎來顯著成長。隨著寵物主人越來越將寵物視為家庭成員，對疫苗、抗寄生蟲藥物和疼痛管理解決方案等獸藥的需求也隨之激增。預防性醫療保健意識的增強以及定期獸醫檢查的重要性的提升，進一步推動了這一趨勢。隨著市場的發展，製藥公司可能會加大研發投入，開發能夠滿足伴侶動物特定健康需求的創新療法，確保未來強勁的成長動能。

此外，獸醫學和技術的進步正在提升伴侶動物藥物的功效。標靶療法和生物製劑的發展正在徹底改變治療格局，為管理寵物的各種健康狀況提供更有效、更安全的選擇。此外，遠距醫療在獸醫護理中的興起也促進了藥品的可及性，使寵物主人能夠遠端諮詢獸醫，並更便捷地獲得必要的藥物。隨著市場不斷適應這些技術進步，對創新和可近性的關注將推動伴侶動物藥物產業的成長。

此外，隨著寵物主人尋求能夠促進整體健康和長壽的產品，人們對寵物健康和預防保健的日益重視也影響伴侶動物藥品市場。旨在支持關節健康、皮膚和毛髮狀況以及消化系統的營養保健品和補充劑正日益受到消費者的歡迎。隨著市場的發展，藥品與保健產品的整合將為製造商創造新的機會，以滿足伴侶動物的整體健康需求。伴侶動物藥品市場注重創新、可近性和消費者教育，未來前景光明，為更優質的寵物照護解決方案鋪平了道路。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了競爭態勢以及領先公司採用的關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新以及潛在投資領域。本部分將深入探討未來市場發展與成長前景。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東非洲各細分市場銷售分析
- 中東非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第10章：伴侶動物藥廠的競爭格局

伴侶動物藥品市場競爭
合作/協作/協議
合併與收購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Merck Animal Health

公司概況
公司收入
產品
最新動態

Zoetis Inc.

公司概況
公司收入
產品
最新動態

Dechra Pharmaceuticals PLC

公司概況
公司收入
產品
最新動態

Elanco Animal Health

公司概況
公司收入
產品
最新動態

Neogen Corporation

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim Animal Health

公司概況
公司收入
產品
最新動態

Aratana Therapeutics

公司概況
公司收入
產品
最新動態

Bayer Animal Health

公司概況
公司收入
產品
最新動態

Norbrook Laboratories

公司概況
公司收入
產品
最新動態

Virbac

公司概況
公司收入
產品
最新動態

Kindred Biosciences

公司概況
公司收入
產品
最新動態

Ceva Sante Animale

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR112114742

Global Companion Animal Pharmaceuticals Market size is anticipated to grow from USD 18.81 Billion in 2024 to USD 30.35 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.46% during the forecast period of 2026 to 2033.

The companion animal pharmaceuticals market is poised for significant growth as pet ownership continues to rise globally, leading to an increased focus on the health and well-being of pets. As pet owners increasingly view their animals as family members, the demand for veterinary medicines, including vaccines, anti-parasitics, and pain management solutions, is surging. This trend is further fueled by the growing awareness of preventive healthcare and the importance of regular veterinary check-ups. As the market evolves, pharmaceutical companies are likely to invest in research and development to create innovative treatments that address the specific health needs of companion animals, ensuring a robust trajectory for future growth.

Moreover, advancements in veterinary medicine and technology are enhancing the capabilities of companion animal pharmaceuticals. The development of targeted therapies and biologics is revolutionizing the treatment landscape, offering more effective and safer options for managing various health conditions in pets. Additionally, the rise of telemedicine in veterinary care is facilitating access to pharmaceuticals, allowing pet owners to consult with veterinarians remotely and obtain necessary medications more conveniently. As the market continues to adapt to these technological advancements, the focus on innovation and accessibility will drive growth in the companion animal pharmaceuticals sector.

Furthermore, the increasing emphasis on pet wellness and preventive care is influencing the companion animal pharmaceuticals market, as pet owners seek products that promote overall health and longevity. Nutraceuticals and supplements designed to support joint health, skin and coat condition, and digestive health are gaining popularity among consumers. As the market evolves, the integration of pharmaceuticals with wellness products will create new opportunities for manufacturers to cater to the holistic health needs of companion animals. With a focus on innovation, accessibility, and consumer education, the future of the companion animal pharmaceuticals market looks promising, paving the way for enhanced pet care solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Animal Type

Dogs
Cats
Horses

By Route of Administration

Oral
Injectable
Topical

By Product

Drugs
Vaccines
Medicated Feed Additives

By Drug Class

Antibiotics
Anti-inflammatory
Heart Worm Drugs
Parasiticides
Nutritional Drugs
Behavioral Drugs
Vaccines
Others

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. COMPANION ANIMAL PHARMACEUTICALS – INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Form
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Product
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY FORM

5.1. Overview By Form
5.2. Historical and Forecast Data Analysis By Form
5.3. Horses Historic and Forecast Sales By Regions
5.4. Cats Historic and Forecast Sales By Regions
5.5. Dogs Historic and Forecast Sales By Regions
5.6. Companion Animals Historic and Forecast Sales By Regions

6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY INDICATION

6.1. Overview By Indication
6.2. Historical and Forecast Data Analysis By Indication
6.3. Dermatologic Diseases Historic and Forecast Sales By Regions
6.4. Infectious Diseases Historic and Forecast Sales By Regions
6.5. Behavioral Diseases Historic and Forecast Sales By Regions
6.6. Orthopedic Diseases Historic and Forecast Sales By Regions

7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Pharmacy Historic and Forecast Sales By Regions
7.4. E-Commerce Historic and Forecast Sales By Regions
7.5. Retail Historic and Forecast Sales By Regions

8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY PRODUCT

8.1. Overview By Product
8.2. Historical and Forecast Data Analysis By Product
8.3. Vaccine Historic and Forecast Sales By Regions
8.4. Biologics Historic and Forecast Sales By Regions

9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East Africa By Segment Sales Analysis
- 9.7.3 Middle East Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE COMPANION ANIMAL PHARMACEUTICALS COMPANIES

10.1. Companion Animal Pharmaceuticals Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF COMPANION ANIMAL PHARMACEUTICALS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Merck Animal Health
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Zoetis Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Dechra Pharmaceuticals PLC
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Elanco Animal Health
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Neogen Corporation
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Boehringer Ingelheim Animal Health
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Aratana Therapeutics
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Bayer Animal Health
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Norbrook Laboratories
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Virbac
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Kindred Biosciences
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Ceva Sante Animale
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments